Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

OptimizeRx Corporation

OPRX ✓ COMPLIANTFree checks used up today ☆ Track — members

NASDAQ · Technology · Online Services ·

USA Micro Cap Analyst: BUY

Last Close

$9.08

▼ -3.09%

Market Cap $171.03M · Vol 29.54K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

37.61

FWD: 8.95

Market Cap

$171.03M

Micro Cap

Div Yield

N/A

EPS Growth

-14.60%

YoY

RSI (14)

57.87

Momentum

Beta

1.23

vs Market

52W High

$22.23

57.85% below

52W Low

$4.54

106.39% above

Volume

29.54K

Avg 49.46K

P/B

1.79

Price-to-book

ROE

N/A

Return on equity

Free Float

85.04%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, OptimizeRx Corporation (OPRX) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does OPRX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+2.60%

+19.16%

+40.56%

+33.53%

YTD

-25.94%

-51.75%

+9.27%

-90.39%

Financials & Valuation

TTM · Annual

Total Revenue	$109.43M
Net Income	$5.13M
Revenue Growth (YoY)	-29.77%
Gross Margin	63.30%
Operating Margin	11.02%
Net Profit Margin	4.69%
ROE	N/A
ROA · ROIC	3.99% · 5.95%

P/E Ratio	37.61
Forward P/E (FY1)	8.95
PEG Ratio	0.36
P/S	2.13
P/B	1.79
P/FCF	12.48
EPS Growth	-14.60%
Outstanding Shares	18.84M

Technical Indicators

50-Day SMA	$8.10
200-Day SMA	$7.42
RSI (14)	57.87
Beta	1.23
52-Week High	$22.23
52-Week Low	$4.54

Volume Today	29.54K
Avg Daily Volume (30D)	49.46K
Relative Volume	0.60x
Volatility (10D)	52.11
Volatility (30D)	48.49
Free Float	85.04%

Analyst Consensus

BUY

Current Price $9.08

Mean Target $12.60

52W Low$4.54 52W High$22.23

Current

Target

$4.54 $22.23

Current Analyst target

+38.77% upside potential · 6 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG001S999P1

ISINUS68401U2042

CountryUSA

Sub-IndustryOnline Services (NEC)

Earnings DateNov 4, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

700.HK Tencent Holdings Limited -2.89% PRX.AS Prosus NV -1.88% UBER Uber Technologies, Inc. +2.14% ABNB Airbnb, Inc. +1.19% DASH DoorDash, Inc. +0.81%

Company Profile

OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.